Solid Biosciences Inc. SLDB Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s change in accrued liabilities?
- Solid Biosciences Inc. (SLDB) reported change in accrued liabilities of -$473K in Q1 2026.
- How has Solid Biosciences Inc.'s change in accrued liabilities changed year-over-year?
- Solid Biosciences Inc.'s change in accrued liabilities decreased by 72.0% year-over-year, from -$275K to -$473K.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.